Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Change in Account Payables (2018 - 2025)

Organogenesis Holdings (ORGO) has 8 years of Change in Account Payables data on record, last reported at -$1.2 million in Q4 2025.

  • For Q4 2025, Change in Account Payables fell 132.08% year-over-year to -$1.2 million; the TTM value through Dec 2025 reached -$528000.0, up 77.74%, while the annual FY2025 figure was -$528000.0, 77.74% up from the prior year.
  • Change in Account Payables reached -$1.2 million in Q4 2025 per ORGO's latest filing, down from -$994000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $4.5 million in Q3 2021 and bottomed at -$4.4 million in Q1 2024.
  • Average Change in Account Payables over 5 years is $204950.0, with a median of -$1.1 million recorded in 2021.
  • Peak YoY movement for Change in Account Payables: skyrocketed 442.54% in 2022, then crashed 2975.4% in 2024.
  • A 5-year view of Change in Account Payables shows it stood at -$1.4 million in 2021, then plummeted by 43.96% to -$2.0 million in 2022, then soared by 277.56% to $3.6 million in 2023, then increased by 2.73% to $3.6 million in 2024, then plummeted by 132.08% to -$1.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Account Payables were -$1.2 million in Q4 2025, -$994000.0 in Q3 2025, and $4.1 million in Q2 2025.